Access cutting-edge chronic urticaria treatment through this clinical trial at a research site in Tampa. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Tampa location
Access chronic urticaria specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic urticaria treatment provided free
Check if you qualify for this chronic urticaria clinical trial in Tampa, FL
No-Cost Study Care
Local to Tampa
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a Phase 3, parallel group, placebo-controlled, double-blind, confirmatory study in patients with CINDU, with an optional Open-label Extension (OLE). The purpose of the core period (52 weeks of treatment) of this study is to evaluate the efficacy, safety, and tolerability of remibrutinib (LOU064) vs. placebo in adults suffering from CINDU inadequately controlled by H1-antihistamines (H1-AHs). The purpose of the OLE period is to collect long-term efficacy, safety, and tolerability data o
Sponsor: Novartis Pharmaceuticals
Yes, this clinical trial (NCT05976243) has an active research site in Tampa, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for chronic urticaria treatment options in Tampa, FL, this clinical trial (NCT05976243) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tampa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic urticaria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all chronic urticaria clinical trials near you to find additional studies recruiting in your area.
See all chronic urticaria clinical trials recruiting in Tampa — not just this study.
Browse Chronic Urticaria Trials in Tampa →